What evidence links gastroesophogeal reflux to worsened asthma, and does prescribing a proton pump inhibitor to patients with asthma help alleviate their asthma symptoms? Dr. Robert Wise, professor of medicine at Johns Hopkins University School of Medicine, discusses the role of proton pump inhibitors for patients with asthma. In patients with poorly controlled asthma and asymptomatic reflux, is a proton pump inhibitor beneficial?
Examining Proton Pump Inhibitors for Asthma
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
What evidence links gastroesophogeal reflux to worsened asthma, and does prescribing a proton pump inhibitor to patients with asthma help alleviate their asthma symptoms? Dr. Robert Wise, professor of medicine at Johns Hopkins University School of Medicine, discusses the role of proton pump inhibitors for patients with asthma. In patients with poorly controlled asthma and asymptomatic reflux, is a proton pump inhibitor beneficial?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
MinuteCE®
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
1.00 credits
<p>Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time</p>
CME/CE
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
0.50 credits
<p>New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure</p>
MinuteCE®
CETP inhibition: Lessons from two decades of clinical trials
0.50 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">CETP inhibition: Lessons from two decades of clinical trials</span></p>
CME/CE
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
<p>AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care</p>
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
<p>mIDH Gliomas Explained: Characteristics and Management Strategies</p>
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
<p>From Diagnosis to Treatment: Challenges in Glioblastoma Care</p>
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
<p>Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data</p>
Clinician's Roundtable
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
<p>Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?